We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

orexin agonist

Advertisement

cGxPJobs Banner

Alkermes Reports Strong Phase 2 Data for Narcolepsy Drug

DUBLIN, April 16, 2026 Alkermes plc has announced new data from its Vibrance-1 Phase 2 clinical study of alixorexton,...

By cGxPwire Editor
April 17, 2026

Read More

Advertisement

cGxPJobs

Recent Posts

01

.Clinical

City of Hope Unveils AI and Cancer Breakthroughs at AACR
April 17, 2026
02

Bio-Pharma

Aligos-Amoytop $445M HBV Licensing Deal Expands Access
April 17, 2026
03

Pharma

Alkermes Reports Strong Phase 2 Data for Narcolepsy Drug
April 17, 2026
04

.Clinical

Janux Therapeutics Doses First Patient in JANX014 Study
April 17, 2026
05

Pharma

Mapi Pharma GA Depot Shows Strong MS Progression Control
April 17, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website